Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
11m agoFatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
37m agoAngle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
38m agoCentury Complete Announces New Homes Coming Soon to Fleming Island, FL
38m agoSprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
39m agoTambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning
Inflarx N.v. logo

Inflarx N.v.

About

Inflarx N.v. (NASDAQ:IFRX) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 9 2026
InflaRx Reports New Mechanistic Data for Izicopan Supporting its Potential as a Best-in-Class C5aR Inhibitor
Mar 31 2026
InflaRx Announces Participation in the Raymond James 2026 Biotech Innovation Symposium
Mar 30 2026
InflaRx Highlights Clinical Activity of Vilobelimab in Pyoderma Gangrenosum in Late-Breaker Oral Presentation at 2026 American Academy of Dermatology Annual Meeting
Mar 19 2026
InflaRx Reports Full Year 2025 Results and Highlights Key Achievements and Expected Milestones
Mar 18 2026
InflaRx Announces Late-Breaker Oral Presentation on Vilobelimab Phase 3 Results in Pyoderma Gangrenosum at 2026 American Academy of Dermatology Annual Meeting

Financials

Revenue
$29.33 K
Market Cap
$65.96 M
EPS
-0.79

Community Chat

Ask AI

6ix6ixAIEvents